DEVELOPMENTS IN THE PHARMACEUTICAL INDUSTRY OF SOVIET ZONE GERMANY

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP80-00809A000600360192-9
• Release Decision: RIPPUB
• Original Classification: C
• Document Page Count: 2
• Document Creation Date: December 22, 2016
• Document Release Date: July 22, 2011
• Sequence Number: 192
• Publication Date: November 14, 1950
• Content Type: REPORT

Sanitized Copy Approved for Release 2011/07/22 :CIA-RDP80-00809A000600360192-9
CLASSIFICATION CONFIDENTIAL 1jO1~FRJL~~'~~
CENTRAL INTELLIGENCE AGENCY REPOR
INFORMATION FROM
FOREIGN DOCUMENTS OR RADIO BROADCASTS CD N0.
SUBJECT
HOW
PUBLISHED
WHERE
PUBLISHED
DATE
PUBLISHED
LANGUAGE
Economic - Pharmaceutical industry
Monthly periodicals
Berlin
Apr - Jul 1950
German
TN If DOCU Y[NT CONTAINS IN CORY ATIOM AI/LCTINO TX[ NA710NAL DLI[YS[
OI TNL UMIi[D STATLS WITNIM TN[ Y[A NIND 01 '~IIO MAO[ ACT LO
Y, f. C., 11 AMD fi. AS AY [M0[0, ITf TRANSYIS SIOM OR TM[ R[Y[LATIOM
Oi Iif fOMT[Nri IM ANT YANM[R TO AN UMAV TMO RIIID I[RfOX IS IRO?
NISIT[D ST LAY. R[IROOU OTION OF TMIf TORY 11 IROXILITI D.
DATE OF
INFORMATION 1950
DATE DIST./~ Nov 1950
N0. OF PAGES 2
SUPPLEMENT TO
REPORT N0.
THIS IS UNEVALUATED INFORMATION
DEVELOPMENPS IN THE PHARMACEUTICAL
INDUSTRY OF SOVIET ZONE GERMANY
jumbers refer to appended sources]
Ia 198, pharmaceuticals worth 160 million marks were produced in
Soviet Zone Germany. Under the plan for 1949 the output was to be in-
creased t~ 208 million East marks, and reportedly this target has been
met. As has been learned, investments for the expansion of the East
German pharmaceutical industry in 1950 will be six times as high as in
1949. The penicillin output is said to exceed domestic requirements
at present. Manufacture of tuberculosis remedies and high-grade vita-
min preparations will be introduced during the current year.
Export of pharmaceuticals is assuming a vital role in East Germany's
.fo:reign trade program. Exports will be considerable in 1950. Culti-
vation of medical herbs has been carried on intensively since 1947, espe-
cially by the people-owned agricultural enterprises.
East Berlin has approximately 90 manufacturers of pharmaceuticals
at present. The most significant of these, for example, the Scheriag
Corporation, the Gruenau Chemical Factory, etc., belong to the zonal
Association of People-Owned Enterprises. In accordance with a recent
reorganization, the following people-owned plante (YEB).;;;baloag,.ao.the;
pharmaceutical group of VVB Berlin, Chemie (Association of People-Owned
Chemical Enterprises, Berlin): Dr Remmler Pharmaceutical. Works, Ras-
pechemie Pharmaceutical Works, Novopin Factory Pharmaceutical Works,
Dickin-Plant Pharmaceutical Works,'Staaken Pharmacy((Dr Albert Bernard,
successor). Together these six enterprises produce approximately 150
pharmaceutical articles, tea veterinary preparations, an3 a number of
cosmetic products. The most important of these six factories is the Dr
Remmler plant, whose yearly output amounts to approximately 1.5 - 2
million East marks. (1)
olyrRleu IoN
_. ~~ ~
Sanitized Copy Approved for Release 2011/07/22 :CIA-RDP80-00809A000600360192-9
- 1 -
CLASSIFICATIGN coNFIDENTIAL : ~ONF~DENTIAL'
 Sanitized Copy Approved for Release 2011/07/22 :CIA-RDP80-00809A000600360192-9
1
~~Nf 6DENTlAI
As a result of scientific research conducted by the Jenapharm Institute
for Microbiology, the Schott and Associates Glass Works in Jena were able tc
increase their output of penicillin in 1949 to 12 times that of the previous
year. The ,joint penicillin outputs of Schott Associates and Madaws in Rade-
beul near Dresden nuw amouui:s to 100 times the 1947 output. The Jena plant,
which at present produces 60 billion Oxford units per month, not only covers
the requirements of the entire Soviet Zone but produces a certain surplus for
export. It'should also be noted that manufacturing costs have been decreased
to an extent which has made possible red~~ction in the price of penicillin
amounting to over 90 percent, compared with 1948.
Streptomycin, Vitamin C and D preparations, and vaccines used in the
treatment of tuberculosis are also attaining significance as export articles,
Other pharmaceutical plants have introduced preparations for the treat-
ment of pernicious anemia and improved prophylactics for nose and throat
diseases. The Thueringer_ pharmaceutical industry has developed new prepara-
tions for the treatment of gall-bladder diseases. A plant in Erfurt has
brought out a preparation for use in the treatment of coronary diseases,
such as angina pectoris. This preparation also dissolves tubercular bacilli.
The RosodoLtwerk, East Germany's largest soa; and cosmetic factory,
has developed a toothpaste which is effective in counteracting inflammation
of the gums. (2)
` SOURCES
1. Chemische Industrie, No 4, Apr 50
2. Export Echo, No 7 Jul 50
GON~'I~~NTIAi
Sanitized Copy Approved for Release 2011/07/22 :CIA-RDP80-00809A000600360192-9